Investment Rating - The investment rating for the company is "Buy" and it is maintained [5][24]. Core Views - The company achieved a revenue of 13.296 billion yuan in 2024, representing a year-on-year growth of 15.77%, while the net profit attributable to shareholders decreased by 41.63% to 450 million yuan [1][10]. - The C-end business is identified as the main source of revenue and gross profit growth, with a revenue contribution of 50.06 billion yuan, reflecting a year-on-year increase of 28.9% [2][12]. - The company faced significant financial losses due to exchange rate fluctuations, particularly in key markets like Brazil and Argentina, leading to a total loss of approximately 5.65 billion yuan in financial expenses, investment income, and fair value changes [3][19]. Financial Performance - In 2024, the company reported a comprehensive gross margin of 19.8%, down 1.4 percentage points year-on-year, with a gross profit of 2.631 billion yuan, an increase of 198 million yuan from the previous year [2][11]. - The revenue from the herbicide, insecticide, and fungicide segments was 9.732 billion yuan, 2.105 billion yuan, and 1.313 billion yuan respectively, with herbicides being the primary revenue driver [11][12]. - The company’s financial forecast estimates net profits of 1.261 billion yuan, 1.409 billion yuan, and 1.594 billion yuan for 2025, 2026, and 2027 respectively, indicating a significant recovery from the previous year's losses [24][26]. Business Model Analysis - The A+B model generated revenue of 8.29 billion yuan, a year-on-year increase of 9.1%, while the C model's revenue increased by 28.9% to 5.006 billion yuan, raising its contribution to total revenue from 34% in 2023 to 38% in 2024 [2][12]. - The gross profit from the C model rose by 29.3% to 1.451 billion yuan, with a gross margin of 29%, up 0.1 percentage points year-on-year [12][19]. Market Expansion - The company has been actively expanding its global marketing network, with 7,700 registration certificates obtained, including new markets in Senegal, Italy, and the UK [22].
润丰股份（301035）：模式C持续推进，汇兑拖累24年业绩